Categories Analysis, Earnings, Technology

Earnings Preview: Disney will totally change the equation for 21st Century Fox

21st Century Fox (FOXA) is set to report its fourth quarter and fiscal year 2018 results on August 8. For the third quarter, Fox posted a 2% decrease in revenues while profits increased by 7%. Revenues in the Cable Network Programming segment increased year-over-year while the Television and Filmed Entertainment segments posted declines.

Analysts expect Fox to post earnings of $0.54 per share for the fourth quarter with revenues of around $7.7 billion. For the full year, revenues are expected to come in at about $30 billion with earnings of $1.92 per share.

Fox has been caught up in an acquisition tangle with Walt Disney (DIS), Comcast (CMCSA) and Sky (SKY) for a while now. This quarter is particularly interesting because the proposed acquisition of Fox’s assets by Disney received both regulatory and shareholder approvals. After engaging in a bidding war with Disney for Fox, Comcast recently bowed out.

The Disney-Fox deal is expected to change the landscape of the media and entertainment industry

Comcast is now pursuing Sky and is facing off with Fox to acquire the British pay-TV provider. Today, Fox submitted its offer document to acquire Sky for GBP14 a share. This offer is still behind Comcast’s offer of GBP14.75 a share.

The Disney-Fox deal was a much-publicized one, and it is expected to change the landscape of the media and entertainment industry. The market can look forward to several interesting changes and any updates regarding the Disney and Sky deals are definitely important ones to look out for.

Fox’s shares are up 32% so far this year. The company’s peer Disney will report its third-quarter earnings today after market close.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top